相关实验视频
Updated: Jun 10, 2025

04:48
Control of Eating Behavior Using a Novel Feedback System
Published on: May 8, 2018
10.9K
严格的碳水化合物限制对于抑制食欲是必要的吗? 在ASKED随机对照试验中
Jessica A Roekenes1, Marthe I Aukan1, Ola Jakob Bomo1
1Obesity Research Group, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
Obesity (Silver Spring, Md.)
|October 16, 2024
概括
这项研究比较了肥胖成年人的低碳水化合物 (CHO) 与高碳水化合物低能耗饮食 (LED). 虽然减肥和症有所不同,但所有饮食中的饥饿水平仍然相似.
科学领域:
- 营养科学 营养科学
- 肥胖问题研究研究
- 代谢研究 代谢研究
背景情况:
- 低能耗饮食 (LED) 是用于减肥的减肥方法.
- 在LED中变化的碳水化合物 (CHO) 含量对症和食欲的影响尚未完全理解.
研究的目的:
- 为了比较三种具有不同CHO量 (低,中,高) 的等热量LED对肥胖成人的症和饥饿的影响.
- 评估体重,组成和食欲相关激素的变化.
主要方法:
- 101名肥胖的成年人被随机分配给8周的同热量1000千卡/天LED (低,中,高CHO:70,100,130g/天).
- 测量包括体重,组成,β-甲酸 (βHB) 对于症,以及饥饿评级.
- 干预后进行了为期4周的再养期.
主要成果:
- 在第8周,在低CHO组和中等和高CHO组之间观察到体重减轻和βHB度的显著差异.
- 在三个CHO组中,饥饿评级没有显著差异.
- 减肥和症因CHO含量而异,但主观饥饿没有显著影响.
结论:
- 虽然1000卡路里/天LED的不同碳水化合物摄入量会影响减肥和症,但它似乎不会显著改变肥胖成年人的饥饿水平.
- 需要进一步的研究来证实这些发现,特别是在LED中较高的CHO摄入量方面.
相关概念视频
Regulation of Food Intake
199
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
199
Hypoglycemia and Glucagon
164
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
164
Overview of Carbohydrate Metabolism
764
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
764
Insulin: Dosing Regimen and Adverse Effects
152
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
152
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
163
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
163
Anorexia Nervosa
47
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
47

